Efficacy and safety of blinatumomab for the treatment of patients relapsing after allogeneic hematopoietic cell transplantation: a systemic review and meta-analysis
Objective We aim to evaluate the efficacy and safety of blinatumomab for the treatment of post-transplant relapse patients with acute lymphoblastic leukemia (ALL).Methods The search was conducted using several databases including the PubMed, Cochrane Library, Embase, Chinese National Knowledge Infra...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis Group
2024-12-01
|
| Sarja: | Hematology |
| Aiheet: | |
| Linkit: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2422151 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|